A market model for PET imaging – Open Symposium 4 April 2019

Professor Alison Murray MBChB, PhD, Roland Sutton Professory of Radiology, University of Aberdeen, Scotland.
“FDG PET in clinical practice and clinical trials of Alzheimer’s Disease and Frontotemporal dementias”
Professor Mats Bergstrom, Former GSK, Roche, Novartis Consultant.
“Imaging and the three Pillars in Drug Development – Options, Pitfalls and Collaboration models”
Dr Magnus Schou, Associate Principal Scientist, AstraZeneca, Karolinska Institutet, Sweden “The use of PET imaging to drive drug discovery and development”
Professor Guus van Dongen, Chair of Preclinical Imaging, Amsterdam University Medical Center. “PET Imaging in Drug Design and Development: costs, benefits and value”
Professor Neil Vasdev, Director at University of Toronto & Centre for Addiction and Mental Health, Totonto, Canada. “Academic-Industrial Partnerships for PET Radiochemistry and Imaging in Drug Development”
Professor Jason S Lewis, Direcot of the MSK Center of Molecular Imaging & Nanotechnology, Memorial Sloan Kettering Cancer Center, New York, USA.“Molecular Imaging: Creating Windows into Cancer”